Enhanced hippocampal miR-32-5p promotes neuronal hyperexcitability and epileptic seizures by targeting KCC2

Xiaolin Zhong1, Ling Chen1, Shixi Zhou2

  • 1The First Affiliated Hospital, Department of Endocrinology and Metabolism, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China; The First Affiliated Hospital, Clinical Medicine Research Center, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.

Insights

MicroRNA-32-5p (miR-32-5p) promotes epilepsy by disrupting neuronal excitation/inhibition balance. Inhibiting miR-32-5p in the hippocampus offers a potential therapeutic strategy for epilepsy.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression involved in epilepsy pathogenesis.
  • MicroRNA-32-5p (miR-32-5p) is upregulated during seizures, but its role in epilepsy remains unclear.

Purpose of the Study:

  • To investigate the function and mechanism of miR-32-5p in neuronal hyperexcitability and epileptic seizures.
  • To identify miR-32-5p as a potential biomarker and therapeutic target for epilepsy.

Main Methods:

  • Measured miR-32-5p levels in epilepsy patients and PTZ-induced seizure mouse models.
  • Utilized systemic knockout and hippocampal-specific knockdown of miR-32-5p in mice.
  • Assessed seizure activity, neuronal spiking, gene expression (IEGs), and KCC2 levels.
  • Performed gain-of-function experiments with KCC2 knockdown.

Main Results:

  • Elevated miR-32-5p levels were found in plasma of epilepsy patients and in the hippocampus/plasma of seizure mice.
  • miR-32-5p knockout/knockdown reduced seizure activity, neuronal hyperexcitability, and hippocampal damage.
  • miR-32-5p regulates the expression of immediate early genes (IEGs) and directly targets KCC2.
  • Restoring KCC2 expression re-balanced neuronal excitation/inhibition (E/I) in the hippocampus.

Conclusions:

  • Hippocampal miR-32-5p promotes neuronal hyperexcitability and epilepsy by targeting KCC2 and disrupting E/I balance.
  • miR-32-5p is a potential biomarker and therapeutic target for hippocampus-related epilepsy.

Related Concept Videos